Update Magazine Issue 1
January/February 2010
FDA & Transparency
January/February 2010Subscription Information
FDLI members receive Update as part of membership.
Additional
copies or back issues are available at $15 each.
Interview With FDLI’s New President and CEO, Susan C. Winckler
, Managing Editor with FDLI, Washington, DC
FDA Transparency Initiative: Opening FDA’s “Black Box”
, Special Assistant to the Principal Deputy Commissioner, Food and Drug Administration, Silver Spring, MD
Potential Loss of 180-Day Exclusivity
, Partner & Licensing Attorney with Pharmaceutical Patent Attorneys LLC, Morristown, NJ
The Confusing Calculus of the Benefit/Risk Ratio in Pharmaceutical
Research―Ethical Questions and Possibilities for Reform
, President of Vision Biotechnology Consulting, Encinitas, CA
Distinguished Service and Leadership Awards: Holiday Reception 2009
, Managing Editor with FDLI, Washington, DC
The Perfect Storm: Weathering the Convergence of Federal, State and Industry Regulations Impacting Pharmaceutical Sales and Marketing Representatives
, Managing Principal in the law firm of Porzio, Bromberg & Newman PC and President and CEO of Porzio Pharmaceutical Services, LLC both in Morristown, NJ and , Counsel to Hoffmann-La Roche Inc., Nutley, NJ
Canadian Corner
Commercial Agreements Among Competitors:A New Antitrust Regime Coming to Canada in March 2010
Global Corner
Increasing Scrutiny of Food Health Claims
Associates’ Corner
Students Corner
the U.S. Health Care Debate
Enforcement Corner
Membership Corner
(Note: All author affiliations are current as of the date of publication of the issue.)